HUMAN SAMPLES Sample Clauses

HUMAN SAMPLES. 15.1 As part of the Protocol, Samples derived from Clinical Study Subjects may be transferred to Sponsor or another organization indicated by Sponsor (hereinafter: “Sponsor’s Designee”), however only if this is arranged for in the ICF. If this done in non-anonymous form, Sponsor and Sponsor’s Designee shall adhere to the provisions of the GDPR by concluding an industry standard processor agreement with each other.
Sample 1Sample 2Sample 3See All (7)
AutoNDA by SimpleDocs
HUMAN SAMPLES. 18.1 As part of the Protocol, Samples may be transferred to Sponsor or another organization indicated by Sponsor only if this is arranged for in the ICF.
Sample 1Sample 2Sample 3See All (5)
HUMAN SAMPLES. As part of the Protocol, Samples may be transferred to Sponsor or another organization indicated by Sponsor only if this is arranged for in the ICF. Sponsor, and the other organization mentioned above in this clause 18.1, shall have the right to store, transfer and use the Samples only in accordance with the applicable Law, the Protocol and ICF (as approved by the Ethics Committee). Principal Investigator shall promptly notify Sponsor of any withdrawal of or changes in the informed consent of a Clinical Trial Subject, which may affect the use of such Clinical Trial Subject’s Samples under this Agreement. In such event, Sponsor shall destroy or return the affected Samples if necessary. Upon termination or expiration of the Clinical Trial, and at least at any time the Samples are no longer needed to be retained by Sponsor for any pending registration purpose related to the Study Drug in relation to the Protocol or as defined in the ICF, or as required per any Applicable Law or regulation the remainder of the Samples in Sponsor’s or any of its designee’s possession will be returned to the Site Parties, retained by the Sponsor in accordance with clause 18.2 or destroyed by the Sponsor, as described in the Protocol and/or the ICF. For the avoidance of any doubt, the control (in Dutch: zeggenschap) of the Samples remains at all times at the Clinical Trial Subjects they are derived from, with the Institution and/or Sponsor acting as custodian of the Samples, as described in the Protocol.
Sample 1Sample 2See All (5)
HUMAN SAMPLES. “Human Samples” means human biological material, including any portion of any tissue, blood, cerebrospinal fluid, cells or sub-cellular structures such as DNA, or any derivative of such human biological material such as pathogens (bacteria, viruses, fungi, parasites), serum, stem cells, cell lines and any human biological product. Access to, provision and exchange of Human Samples under the Project shall be carried out pursuant to the terms of this Consortium Agreement, any Study Protocols and the following principles: only Parties that are [hospitals //or// university/university hospital] shall be allowed to permanently store Human Samples. Collected Human Samples will be aliquoted (split) into fragments of the original sample at the microbiology institutions of each Party that is a [university/university hospital]. One aliquot will be shipped to the Party/ies performing examinations such as sequencing and metabolomics as described in the Project Description and/or the respective Study Protocol. Leftover aliquots will be stored at each microbiology institution for at least 5 years; Human Samples shall not be disposed of or acquired as such for research purposes in return for payment or other non-cash advantage. However, the foregoing shall not apply to operations such as preparation, transport, storage etc. of Human Samples; The Parties may only use the Human Samples received under this Consortium Agreement for the Project and shall either return or destroy the Human Samples after the related activities to the providing Party, or if requested by the patient.
Sample 1Sample 2Sample 3See All (4)
HUMAN SAMPLES. All human samples collected and retained in connection with Clinical Studies involving a Licensed Antibody or Licensed Product that are performed under a Development Plan and Budget or for which costs are shared as Allowable Expenses (together with compilations of Information comprising annotations regarding patient histories or correlating patient outcomes, with respect to such samples, the “Human Samples”) shall be a shared resource of the Parties. Unless otherwise agreed by the Parties, all Human Samples shall be maintained and stored at the facilities of a Third Party reasonably agreed by the Parties, and the fees paid to such Third Party in connection with such maintenance and storage shall be shared equally by the Parties. Each Party shall access and use the Human Samples, and authorize Affiliates and Third Parties to access or use the Human Samples, outside of the Collaboration Programs only as reasonably agreed by the Parties. If the Parties are unable to reach agreement on the storage, access to or use of the Human Samples, the matter shall be determined pursuant to Section 13.7.4 below. Notwithstanding anything herein to the contrary, the Parties agree that in no case shall either Party propose any access or use of the Human Samples which would (1) conflict with the terms of the informed consent under which the relevant Patient Sample was collected or (2) violate Applicable Law. Either Party shall have the right to access such samples in connection with such Party’s performance of its Party Development Activities.
Sample 1Sample 2
HUMAN SAMPLES. The Beneficiaries must use Human Samples under and pursuant to this Consortium Agreement and the Grant Agreement in compliance with their respective obligations under applicable international and national laws and regulations.
Sample 1Sample 2
HUMAN SAMPLES. The Beneficiaries must use Human Samples under and pursuant to this Consortium Agreement and the Grant Agreement in compliance with their respective obligations under applicable international and national laws and regulations. Human Samples - representation and warranty. Each Beneficiary represents and warrants that any Human Samples required for use in the Project that are obtained, handled or used by it (i) will be obtained, handled or used in accordance with all relevant laws and regulations (and where applicable, local ethical guidelines) regarding the collection, use, transport and subsequent disposal of Human Samples and (ii) that any ethics committee approvals and Donor informed consents – in so far needed - required for performing the Action or to conduct Research Use pursuant to the provisions of the Consortium Agreement (or otherwise determined in a bilateral agreement between the Human Sample provider and the Human Sample receiver), will be obtained prior to the commencement of the respective part of the Allocated Work respectively the envisaged Research Use. When processing Personal Data in relation to Human Samples under or pursuant to the Grant Agreement and/or this Consortium Agreement, the relevant Beneficiaries will comply with the terms and conditions as set out in Appendix 3. Data agreements. The relevant Beneficiaries may need to enter into appropriate additional agreements (e.g. data processing and/or data transfer agreements), to implement, regulate and facilitate appropriate provisions on the transfer and processing of data (including Personal Data) in relation to the Project, including the case being data transfers of data to a database/platform or biobank within the Project. The draft of such additional agreements shall in such case be initiated by the Beneficiary providing the data to another Beneficiary/Third Party (data receiver), regardless of the status of the Beneficiary providing the data per applicable Data Protection Legislation, before the transfer or processing of such data actually occurs, unless agreed otherwise in writing and beforehand between the data provider and data receiver or otherwise covered in the Data Management Plan. Such agreements may not contain provisions contradicting this Consortium Agreement (including the provisions of Appendix 3 to the extent and in so far applicable) or limiting any usage rights already granted under this Consortium Agreement, and are subject to applicable Data Protection Legisla...
Sample 1
AutoNDA by SimpleDocs

Related to HUMAN SAMPLES

  • Samples The Contractor shall submit the following samples of Materials and relevant information to the Authority’s Engineer for pre-construction review:

  • Environment, Health, and Safety 24.4.1. The Supplier and its staff (and/or any sub-supplier and/or subcontractor) shall comply with the laws and regulations in force related to protection of the environment, the health and safety instructions applicable to the Goods and Services performed pursuant to the Contract and especially, if appropriate, to the Goodsand Services performedon any Site by a third company.

  • FDA As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (“FDA”) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (“FDCA”) that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a “Pharmaceutical Product”), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.

  • Animals The Hirer shall ensure that no animals (including birds) except guide dogs are brought into the premises, other than for a special event agreed to by the Village Hall. No animals whatsoever are to enter the kitchen at any time.

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

  • Health and Safety 16.01 The Employer, Union and the employees shall comply with the provisions of the Occupational Health and Safety Act where and when applicable. The Employer shall provide working conditions at all times which are not prejudicial to the health or efficiency of the workers. Employees are required to report to their Employer any unsafe work conditions, or violation of any safe work policies or procedures established by the Employer, or any violation of relevant safe work legislation.

  • Product Testing Upon request, Customer shall provide Operator a laboratory report for each Product delivery by Customer or Customer’s supplier. Operator will not be obligated to receive Contaminated Product for throughput through the Pipelines, nor will Operator be obligated to accept Product that fails to meet the applicable quality specifications for the Berths under the BAUTA and any Terminal Service Orders issued thereunder.

  • Labeling Upon request, Lessee will xxxx the Equipment indicating Lessor's interest with labels provided by Lessor. Lessee will keep all Equipment free from any other marking or labeling which might be interpreted as a claim of ownership.

Time is Money Join Law Insider Premium to draft better contracts faster.